Effects on cognition of DMTs in multiple sclerosis: moving beyond the prevention of inflammatory activity
Academic Article
Publication Date:
2022
abstract:
In this review, we critically summarize recent findings derived from randomized controlled trials (RCTs), observational studies and meta-analyses that have been published in the last 3 years and that included the effects of DMTs on cognitive performances among their outcomes.
Iris type:
1.1.3. Articolo in Rivista - Editorial, Comment, Reply
Keywords:
Cognition; Disease modifying drugs; Multiple sclerosis
List of contributors:
Preziosa, P.; Conti, L.; Rocca, M. A.; Filippi, M.
Published in: